The estimated Net Worth of Roberto Guerciolini is at least 23.6 千$ dollars as of 7 December 2016. Roberto Guerciolini owns over 24,000 units of Wave Life Sciences stock worth over 23,600$ and over the last 8 years Roberto sold WVE stock worth over 0$.
Roberto has made over 3 trades of the Wave Life Sciences stock since 2016, according to the Form 4 filled with the SEC. Most recently Roberto exercised 24,000 units of WVE stock worth 59,280$ on 7 December 2016.
The largest trade Roberto's ever made was exercising 24,000 units of Wave Life Sciences stock on 7 December 2016 worth over 59,280$. On average, Roberto trades about 8,500 units every 33 days since 2016. As of 7 December 2016 Roberto still owns at least 4,000 units of Wave Life Sciences stock.
You can see the complete history of Roberto Guerciolini stock trades at the bottom of the page.
Roberto's mailing address filed with the SEC is C/O WAVE LIFE SCIENCES LTD.,, 733 CONCORD AVE., CAMBRIDGE, MA, 02138.
Over the last 9 years, insiders at Wave Life Sciences have traded over 19,158,839$ worth of Wave Life Sciences stock and bought 18,619,108 units worth 128,204,225$ . The most active insiders traders include Plc Gsk、Capital Management, L.P.Ra ...、Capital Management, Llc Kol.... On average, Wave Life Sciences executives and independent directors trade stock every 43 days with the average trade being worth of 1,569,819$. The most recent stock trade was executed by Paul Bolno on 21 August 2024, trading 48,366 units of WVE stock currently worth 279,555$.
wave life sciences ltd. (nasdaq: wve) is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. given the unique versatility of its chemistry platform, wave’s pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded rnai.
Wave Life Sciences executives and other stock owners filed with the SEC include: